Segment Information - Reportable Segment Information (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Net sales:
Net sales	$ 3,226	$ 2,465
Segment Adjusted Operating EBITDA:
Segment Adjusted Operating EBITDA	702	569
Other Depreciation and Amortization	303	242
Restructuring and other charges, net	(2)	(4)
Shareholder Activism Related Costs	3	7
Business Divestiture Costs	(30)	0
Severance Costs	(4)	(3)
Interest expense	(72)	(65)
Other income, net	16	7
Income before taxes	285	(54)
Corporate and Other
Segment Adjusted Operating EBITDA:
Integration-related costs	(18)	(38)
Restructuring and other charges, net	(2)	(4)
Taste
Segment Adjusted Operating EBITDA:
Restructuring and other charges, net	(2)	(3)
Scent [Member]
Segment Adjusted Operating EBITDA:
Restructuring and other charges, net	0	(1)
Operating Segments | Health & Biosciences
Net sales:
Net sales	661	426
Segment Adjusted Operating EBITDA:
Segment Adjusted Operating EBITDA	192	128
Operating Segments | Pharma Solutions
Net sales:
Net sales	249	162
Segment Adjusted Operating EBITDA:
Segment Adjusted Operating EBITDA	65	43
Operating Segments | Taste
Net sales:
Net sales	1,731	1,308
Segment Adjusted Operating EBITDA:
Segment Adjusted Operating EBITDA	329	270
Operating Segments | Scent [Member]
Net sales:
Net sales	585	569
Segment Adjusted Operating EBITDA:
Segment Adjusted Operating EBITDA	116	128
Nutrition & Biosciences, Inc | Corporate and Other
Segment Adjusted Operating EBITDA:
N&B Inventory Step-Up Costs	0	(182)
Transaction related costs	0	(89)
Frutarom | Corporate and Other
Segment Adjusted Operating EBITDA:
Transaction related costs	$ (1)	$ 0